PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2001. Start Trial.
Date Value
November 13, 2026 3.024
November 12, 2026 2.966
November 11, 2026 2.938
November 10, 2026 2.881
November 09, 2026 2.920
November 06, 2026 2.895
November 05, 2026 2.839
November 04, 2026 2.844
November 03, 2026 2.848
November 02, 2026 2.765
October 30, 2026 2.860
October 29, 2026 2.818
October 28, 2026 2.716
October 27, 2026 2.744
October 26, 2026 2.714
October 23, 2026 2.678
October 22, 2026 2.732
October 21, 2026 2.76
October 20, 2026 2.776
October 19, 2026 2.807
October 16, 2026 2.820
October 15, 2026 2.793
October 14, 2026 2.767
October 13, 2026 2.803
October 12, 2026 2.797
Date Value
October 09, 2026 2.793
October 08, 2026 2.667
October 07, 2026 2.662
October 06, 2026 2.659
October 05, 2026 2.695
October 02, 2026 2.686
October 01, 2026 2.671
September 30, 2026 2.691
September 29, 2026 2.670
September 28, 2026 2.607
September 25, 2026 2.628
September 24, 2026 2.697
September 23, 2026 2.616
September 22, 2026 2.650
September 21, 2026 2.686
September 18, 2026 2.614
September 17, 2026 2.628
September 16, 2026 2.584
September 15, 2026 2.632
September 14, 2026 2.597
September 11, 2026 2.481
September 10, 2026 2.438
September 09, 2026 2.471
September 08, 2026 2.465
September 04, 2026 2.438

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Merck & Co., Inc. 5.444
Bristol Myers Squibb Co. 2.595
Eli Lilly & Co. 15.14
Pfizer Inc. 2.596
Sanofi 2.186

PS Ratio Related Metrics